Content area

|
|

Osteoporosebehandling kan pauseres efter individuel vurdering

Osteoporosebehandling med alendronat og zoledronsyre kan pauseres efter individuel vurdering.
Forfatter(e)
Pia A. Eiken1, 2 & Bo Abrahamsen3, 4 1) Kardiologisk, Nefrologisk, Endokrinologisk Afdeling, Nordsjællands Hospital, Hillerød 2) Institut for Klinisk Medicin, Københavns Universitet 3) Medicinsk Afdeling, Holbæk Sygehus 4) Det Sundhedsvidenskabelige Fakultet, Syddansk Universitet Ugeskr Læger 2017;179:V05160327
Reference: 
Ugeskr Læger 2017;179:V05160327
Blad nummer: 
Sidetal: 
2-9
Osteoporosis treatment can be discontinued based on an individual assessment
In most patients, treatment of osteoporosis is a long-term challenge. Because alendronate and zoledronic acid accu­mulate in bone with some persistent antifracture efficacy after therapy, it is reasonable to consider a “drug holiday” for low-risk patients. It is recommended that the duration and length of drug holiday should be individualized for each patient. For all other bisphosphonates data are limited. For other antiresorptive and anabolic agents “drug holiday” is not recommended.
Du skal være logget ind for at læse denne artikel
Log ind

Right side